Skip to main content
CTEV
NYSE Trade & Services

Claritev Reports Increased Q1 Net Loss and Worsened Free Cash Flow Despite Revenue Growth

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$26.47
Mkt Cap
$449.114M
52W Low
$12.04
52W High
$74.07
52W Position info
120% above low
Off High info
64% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

CTEV has more than doubled off its 52-week low of $12.04.

Summary

Claritev Corporation reported mixed first-quarter 2026 results, with revenue and Adjusted EBITDA growth offset by a larger net loss and significantly negative free cash flow, while maintaining most full-year guidance.


Key Events · Earnings and Guidance · CTEV

  • Q1 2026 Revenue Growth

    Revenues increased by 5.8% to $244.7 million for the first quarter of 2026 compared to the prior year.

  • Increased Net Loss

    The company reported a net loss of $73.6 million, an increase from $71.3 million in Q1 2025, with diluted EPS worsening to $(4.41).

  • Worsened Free Cash Flow

    Free cash flow deteriorated significantly to negative $92.5 million for Q1 2026, compared to negative $68.9 million in the same period last year.

  • Maintained Full-Year Guidance

    Claritev largely maintained its full-year 2026 guidance for Adjusted EBITDA and Free Cash Flow, with a slight increase to the low end of revenue guidance.


Analysis · CTEV · Trade & Services

Claritev's Q1 2026 results present a mixed financial picture. While the company achieved a 5.8% increase in revenues and a 3.4% rise in Adjusted EBITDA, the net loss widened to $73.6 million and free cash flow significantly worsened to negative $92.5 million. This continued cash burn, alongside a relatively low cash balance of $21.3 million, raises concerns about liquidity and operational efficiency despite management's positive commentary and a slight upward revision to the low end of revenue guidance. Investors should monitor the company's ability to improve cash flow and manage its debt obligations in upcoming quarters.

At the time of this filing, CTEV was trading at $26.47 on NYSE in the Trade & Services sector, with a market capitalization of approximately $449.1M. The 52-week trading range was $12.04 to $74.07. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CTEV - Latest Insights

CTEV
Jul 30, 2026, 9:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $23.40
Real-time Price: $22.71 info
Change: -$0.690 (-3%) info
Market Cap: $387.155M info
CTEV
Jun 22, 2026, 4:03 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $28.77
Real-time Price: $22.71 info
Change: -$6.06 (-21%) info
Market Cap: $387.155M info
CTEV
Jun 22, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $28.44
Real-time Price: $22.71 info
Change: -$5.73 (-20%) info
Market Cap: $387.155M info
CTEV
May 18, 2026, 12:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.71
Real-time Price: $22.71 info
Change: +$11.00 (+94%) info
Market Cap: $387.155M info
CTEV
May 07, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.21
Real-time Price: $22.71 info
Change: -$1.50 (-6%) info
Market Cap: $387.155M info